EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships

Siew Lee Cheong, Gopalakrishnan Venkatesan, Priyankar Paira, Ramasamy Jothibasu, Alexander Laurence Mandel, Stephanie Federico, Giampiero Spalluto, Giorgia Pastorin

International Journal of Medicinal Chemistry · 2011

DOI: 10.1155/2011/480652 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Medicinal Chemistry, 2011. Verfasst von Siew Lee Cheong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National University of Singapore, 3 Science Drive 2, Singapore 117543. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Medical Research Council, National University of Singapore.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the past few decades, medicinal chemistry research towards potent and selective antagonists of human adenosine receptors (namely, A 1 , A 2A , A 2B , and A 3 ) has been evolving rapidly. These antagonists are deemed therapeutically beneficial in several pathological conditions including neurological and renal disorders, cancer, inflammation, and glaucoma. Up to this point, many classes of compounds have been successfully synthesized and identified as potent human adenosine receptor antagonists. In this paper, an overview of the structure-activity relationship (SAR) profiles of promising nonxanthine pyrazolo derivatives is reported and discussed. We have emphasized the SAR for some representative structures such as pyrazolo-[4,3- e ]-1,2,4-triazolo-[1,5- c ]pyrimidines; pyrazolo-[3,4- c ] or -[4,3- c ]quinolines; pyrazolo-[4,3- d ]pyrimidinones; pyrazolo-[3,4- d ]pyrimidines and pyrazolo-[1,5- a ]pyridines. This overview not only clarifies the structural requirements deemed essential for affinity towards individual adenosine receptor subtypes, but it also sheds light on the rational design and optimization of existing structural templates to allow us to conceive new, more potent adenosine receptor antagonists.

Autor:innen und Institutionen

  • Department of Pharmacy, National University of Singapore, 3 Science Drive 2, Singapore 117543.
  • Dipartimento di Scienze Farmaceutiche, Università degli Studi di Trieste, Piazzale Europa 1, 34127 Trieste, Italy.

Förderung

  • National Medical Research Council
  • National University of Singapore

Zitieren

APA

Cheong, S. L., Venkatesan, G., Paira, P., Jothibasu, R., Mandel, A. L., Federico, S., Spalluto, G., & Pastorin, G. (2011). Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships. International Journal of Medicinal Chemistry. https://doi.org/10.1155/2011/480652

Vancouver

Cheong SL, Venkatesan G, Paira P, Jothibasu R, Mandel AL, Federico S, et al. Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships. International Journal of Medicinal Chemistry. 2011. doi:10.1155/2011/480652

BibTeX
@article{Cheong2011,
  author = {Cheong, Siew Lee and Venkatesan, Gopalakrishnan and Paira, Priyankar and Jothibasu, Ramasamy and Mandel, Alexander Laurence and Federico, Stephanie and Spalluto, Giampiero and Pastorin, Giorgia},
  title = {Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships},
  journal = {International Journal of Medicinal Chemistry},
  year = {2011},
  doi = {10.1155/2011/480652}
}
Kostenlos starten →